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Biological cellular systems are groups of cells sharing a set of characteristics, mainly key
function and origin. Phagocytes are crucial in the host defense against microbial infection.
The previously proposed phagocyte cell systems including the most recent and presently
prevailing one, the mononuclear phagocyte system (MPS), grouped mononuclear cells but
excluded neutrophils, creating an unacceptable situation. As neutrophils are archetypical
phagocytes that must be members of comprehensive phagocyte systems, Silva recently
proposed the creation of a myeloid phagocyte system (MYPS) that adds neutrophils to the
MPS. The phagocytes grouped in the MYPS include the leukocytes neutrophils, inﬂam-
matory monocytes, macrophages, and immature myeloid DCs. Here the justiﬁcations
behind the inclusion of neutrophils in a phagocyte system is expanded and the MYPS
are further characterized as a group of dedicated phagocytic cells that function in an inter-
acting and cooperative way in the host defense against microbial infection. Neutrophils and
macrophages are considered the main arms of this system.
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INTRODUCTION
When infectious agents pass the peripheral defenses and invade
sterile body territories they face innate antimicrobial mechanisms.
The pathological result of the presence of a microbe within a
host is dependent on the virulence of the pathogen and on the
defense competence of the host (Finlay and Falkow, 1989; Casade-
vall and Pirofski, 2001). When functioning as a pathogen, the
infectious agent is living from its pathogenicity, but when the host
antimicrobial protective mechanisms dominate there is the efﬁ-
cient protective intervention of several immune and non-immune
cells. This intervention is crucially centered on the antimicrobial
activities of phagocyte cells, mainly macrophages and neutrophils.
Although epithelial cells, ﬁbroblasts, and other cells can phago-
cytose, in this text the term phagocytes is used for cells whose
main function is phagocytosis and that have been classically
called professional or dedicated phagocytes, namely neutrophils,
inﬂammatory monocytes, macrophages, and immature dendritic
cells (DCs).
Phagocytosis is the process by which eukaryotic cells engulf
large particles (>0.5 μm) including prokaryotic and eukaryotic
cells. When functioning as a microbe-killing mechanism, phago-
cytosis triggers rich antimicrobial processes that use a large array
of mechanisms involving oxidants like reactive oxygen/nitrogen
species (ROS, RNS), granule proteins, and iron-withholding
molecules (reviewed in Flannagan et al., 2009). Although phago-
cytes operate using phagocytic and non-phagocytic mechanisms
(Silva, 2010a,b), phagocytosis is the activity that confers their
typical character.
METCHNIKOFF, PHAGOCYTES, AND PHAGOCYTOSIS
While lower eukaryotes use phagocytosis mainly for the acquisi-
tion of nutrients, phagocytosis in metazoans is primarily carried
out by the specialized professional phagocytes, macrophages, and
neutrophils, for a wide range of tasks that include, but are
not restricted to, uptake and destruction of invading pathogens
(Dale et al., 2008; Cassatella et al., 2009; Silva, 2010a,b).
Although the uptake of particles by cells has been reported
before, Metchnikoff, stimulated by Carl Claus, introduced the
term “phagocyte,” and the theory of phagocytosis and phagocytic
cells is a fundamental contribution by Metchnikoff. His semi-
nal observations behind the phagocytosis theory are extensively
discussed in two publications translated to English (Metchnikoff,
1893, 1905) and in biographic texts (see for example Tauber,
2003; Kaufmann, 2008). Metchnikoff understood that phagocy-
tosis represents a central defense mechanism of the host against
microbial invaders. The main roots of the theory of phagocytic
cells originated from the initial observations made in starﬁsh
larva and later in vertebrates. In 1984, working with natural yeast
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infection in Daphnia, he reported on the antimicrobial activity of
phagocytes. In 1887, he described the two types of professional
phagocytes in vertebrates, macrophages and neutrophils, the lat-
ter initially called “microphages” (Metchnikoff, 1893). Another
important Metchnikoff ’s contribution to the ﬁeld of phagocytosis
was the understanding that the lamprey’s larvae (ammocoetes)was
the lowest biological entity where macrophages and neutrophils
coexisted (Metchnikoff, 1905).
The morphological antinomy macrophage/microphage origi-
nated by Metchnikoff, based on the differences in morphological
size of the two phagocytes (Metchnikoff, 1893), does not have
a corresponding parallel with respect to their function. Indeed,
when considering the roles of the two phagocytes against micro-
bial infection, Metchnikoff calls neutrophils “principal combat-
ants” and throughout his publications and lectures he stressed
that both macrophages and neutrophils were important play-
ers: “Phagocytosis is exhibited not only by the macrophages
but also, in a high degree, by the microphages which stand
out as the defensive cells par excellence against microorganisms”
(Metchnikoff, 1905).
NEUTROPHILS: ARCHETYPES OF PHAGOCYTE CELLS
In spite of the importance Metchnikoff attributed to neutrophils
as a phagocyte archetype, the post-Metchnikoff evolving trend
was to consider macrophages the essential phagocytes minimiz-
ing the importance of neutrophils. This macrophage-centric view
was reﬂected in the exclusion of the neutrophil in the initial
attribution, in 1967, of the label “professional phagocytes” to
macrophages (Rabinovitch, 1967) and in the creation of systems
of phagocytic cells that excluded the neutrophil (Aschoff, 1924;
Volterra, 1927; van Furth et al., 1972). This cell was considered at
the time a terminally differentiated phagocyte with very limited
functional capacities. However, the evolution of knowledge about
phagocytes progressively led to a new concept of neutrophils as
archetypical phagocytic and modulator immune cells, with an
origin common to that of the macrophages (Cassatella, 1995,
1999; Rabinovitch, 1995; Akashi et al., 2000; Cassatella et al., 2009;
Borregaard, 2010; Silva, 2010b; Costantini and Cassatella, 2011;
Mantovani et al., 2011). This new perspective of the neutrophil
highlighted novel unexpected capabilities for this essential com-
ponent of the immune system, which is still under further study
nowadays.
Although varying among mammals, the antimicrobial capac-
ity of neutrophils is higher than that of macrophages (Levy,
2004; Segal, 2005). Neutrophils are equipped with a huge assort-
ment of microbicidal mechanisms and use multiple antimicrobial
molecules stored in enormous amounts in granules (Borregaard
and Cowland, 1997; Segal, 2005). Production of ROS is most
prominent in neutrophils as comparedwithmacrophages (Nathan
and Shiloh, 2000). Several antimicrobial proteins that are an
important part of the neutrophil arsenal are lacking or scarce in
the tissue macrophage (Levay andViljoen, 1995; Lehrer and Ganz,
2002; Selsted and Ouellette, 2005). This is the case of defensins
and cathelicidins, the major families of mammalian antimicrobial
peptides of neutrophils (Ganz, 2003), and of lactoferrin (Levay
and Viljoen, 1995). The bactericidal/permeability-increasing pro-
tein (BPI) is also speciﬁc of neutrophils (Weiss and Olsson, 1987).
Myeloperoxidase (MPO), which is an important enzyme involved
in oxidative antimicrobial mechanisms of neutrophils, is present
in circulating mammal monocytes but is lost as these mature into
macrophages (Klebanoff, 2005), which correlates with decay in
antimicrobial activity (Locksley et al., 1987).
PHAGOCYTE CELL SYSTEMS
Biological cellular systems are groups of cells that share common
features, mostly function and origin (Aschoff, 1924; van Furth
et al., 1972). Following the pioneer studies by Metchnikoff sev-
eral systems of phagocytic cells have been created and, strangely,
all these were conﬁned to mononuclear cells and excluded neu-
trophils. One argument used in the proposal of thesemononuclear
systems was that Metchnikoff considered macrophages as the
major phagocytic cells, an interpretation that, as discussed above,
is not justiﬁed. Aschoff (1924) created the “reticuloendothe-
lial system” (RES), formed by mononuclear cells with presumed
phagocytic capacity but neutrophils were left outside for not
being considered major phagocytes (Aschoff, 1924). Following
progressive criticisms to the previous systems, the “mononuclear
phagocyte system” (MPS) was created in 1969 based on a proposal
by van Furth and coworkers at aConference dedicated toMononu-
clear Phagocytes. This proposal was formally published (van Furth
et al., 1972) and described theMPS as a systemof dedicated phago-
cytic cells with similar morphology, function, origin and kinetics,
grouping monocytes/macrophages, and their precursors but again
excluding neutrophils. This exclusion was based on the argument
that “although polymorphonuclear phagocytes are mononuclear
too, they belong to another cell line because of their different
origin and divergent kinetic and functional behavior” (van Furth
et al., 1972). When the MPS was proposed, knowledge on myel-
ogenesis was limited and the common origin of neutrophils and
macrophages was not known, the neutrophils being considered to
belong to a cell line separated from that of the MPS members and
to be a terminally differentiated phagocytic effector with limited
kinetic and functional capacities.
Comprehensive phagocyte cell systems must include neu-
trophils and Silva recently proposed an enlarged system grouping
dedicated phagocytic cells including neutrophils (Silva, 2010a). All
dedicated phagocytes are of the myeloid lineage (Figure 1) as they
originate in the “common myeloid progenitors” (CMPs) via the
“granulocyte/macrophage lineage-restricted progenitors” (GMPs;
Akashi et al., 2000; Iwasaki and Akashi, 2007). Thus, the new sys-
tem was labeled myeloid phagocyte system (MYPS; Silva, 2010a).
Here the justiﬁcations for such proposal are extended and the
MYPS are further characterized focusing on human and mouse
studies.
THE MEMBERS OF THE MYPS
The leukocytes of the MYPS share origin, avid phagocytic
abilities, and kinetics. Regarding their morphology, the pre-
cursor forms of all members of the MYPS are similar except
for the mature circulating neutrophil. Mature neutrophils are
mononuclear like the other members of the MYPS but the ter-
minal mature form is morphologically differentiated and has
a polylobed nucleus. This has been considered as a structural
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FIGURE 1 | Main steps and players of myelopoiesis in the context of
the MYPS. Graph depicting one interpretation of the still evolving view of
the myelopoiesis pathways (blue arrows) associated with the poiesis of the
members of the MYPS in mice and humans. This interpretation takes into
consideration recent publications whose references are given below (see
also the reviews Friedman, 2002; Iwasaki and Akashi, 2007; Varol et al.,
2009; Geissmann et al., 2010b). HSCs give rise to CMPs (1) (Akashi et al.,
2000; Manz et al., 2002). CMPs originate GMPs (2) and MEPs (3) (Akashi
et al., 2000; Manz et al., 2002). GMPs differentiate into Monocytes (4),
Eosinophils, Basophils, Mast cells, and Neutrophils (5) (Akashi et al., 2000;
Iwasaki and Akashi, 2007) and MDPs (7) (Iwasaki and Akashi, 2007). An
alternative to the view that MDPs originate from GMPs considered that
MDPs would directly derive from CMPs; Fogg et al., 2006). Monocytes
mature into Macrophages (6) (van Furth et al., 1973; Akashi et al., 2000;
Sunderkotter et al., 2004; Fogg et al., 2006). The pathways to myeloid DCs
include MDPs [originated from GMPs (7); Iwasaki and Akashi, 2007] that
differentiate into CDPs (8) (Onai et al., 2007; Liu et al., 2009) and these give
rise to Immature myeloid DCs (9) [that originate cDCs (10)], and pDCs (11)
(Naik et al., 2006, 2007). The members of the MYPS are highlighted in bold.
MYPS, myeloid phagocyte system; HSCs, hematopoietic stem cells;
CMPs, common myeloid precursors; GMPs, granulocyte/macrophage
precursors; MEPs, megakaryocyte/erythrocyte progenitors; MDPs,
macrophage/DC progenitors; CDPs, common DC progenitors; cDCs,
conventional (or classic) myeloid DCs; pDCs, plasmacytoid DCs.
specialization that facilitates the mechanical deformation, allow-
ing neutrophils to “squeeze” through tight spaces when moving to
inﬂammatory/infectious foci.
The list of MYPS members proposed below may have to be
altered according to the continuously evolving knowledge in this
area. This is particularly relevant for DCs since they share to a
great extent the origin and function of other cell members of the
MYPS. Of notice, all except neutrophils are antigen-presenting
cells. However, since the concept of MYPS, as it stands presently,
requires a high phagocytic proﬁle, among the DC cell populations,
only immature myeloid DCs were included.
NEUTROPHILS
All granulocytes are phagocytic but neutrophils (mouse and
human key markers: CD66b, LY6-G) are the only exhibiting avid
phagocytosis. As already stressed, neutrophils have been acquir-
ing a progressive status of fundamental phagocytic immune cells
(Cassatella, 1995, 1999; Rabinovitch, 1995; Cassatella et al., 2009;
Borregaard, 2010; Silva, 2010b; Costantini and Cassatella, 2011;
Mantovani et al., 2011) with phagocytic abilities superior to those
of macrophages (see Section Neutrophils: archetypes of phago-
cyte cells). Comprehensive reviews on these leukocytes include
recent contributions (Nathan, 2006; Nauseef, 2007; Dale et al.,
2008; Borregaard, 2010).
INFLAMMATORY MONOCYTES
Inﬂammatory monocytes constitute a heterogeneous group of
macrophage progenitors and have been divided into two main
subsets: a short-lived“inﬂammatory subset” (key markers; mouse:
CD11b, F4/80, Ly6 C; human: CD11b, LY6C) that homes to
inﬂamed tissue, and a“resident subset,”with a longer half-life, that
homes to non-inﬂamed tissues (Geissmann et al., 2003). Inﬂam-
matory monocytes are phagocytic and use this capacity as an
antimicrobial mechanism (Grage-Griebenow et al., 2001; Sun-
derkotter et al., 2004; Serbina et al., 2008; Soehnlein et al., 2008c).
MACROPHAGES
Macrophages (key markers; mouse: CD11b (Mac-1), F4/80;
human: CD33) have remarkable phagocytic abilities that largely
surpass their contribution to direct antimicrobial host mecha-
nisms of defense. Many recent comprehensive reviews on these
phagocytes are available (Hume, 2006; Mosser and Edwards, 2008;
Serbina et al., 2008; Pluddemann et al., 2011).
IMMATURE MYELOID DCs
Dendritic cells (Steinman and Banchereau, 2007) were not
included in the MPS based in part on the interpretation that they
“are not highly phagocytic” (van Furth et al., 1972). They are a
group of primarily antigen presenting and immunomodulatory
cells whose distinctiveness has been debated (Hume, 2008; Geiss-
mann et al., 2010a). Mature DCs are not considered dedicated
phagocytes andhavenot been included in the groupof professional
phagocytes (Rabinovitch,1995). MatureDCs have a limited capac-
ity for lysosomal degradation of ingested material (Delamarre
et al., 2005) and, in contrast to neutrophils and macrophages, are
not involved in direct pathogen clearance (Savina and Amigorena,
2007). On the other hand, immature myeloid DCs are phagocytic
(Inaba et al., 1993b; Steinman and Swanson, 1995) and have direct
effector antimicrobial activities (Banchereau and Steinman, 1998;
Banchereau et al., 2000). Thus, they are included as members of
the MYPS.
NEUTROPHILS AS ESSENTIAL MEMBERS OF
PHAGOCYTE CELL SYSTEMS
Several arguments justify the inclusion of neutrophils in any
comprehensive phagocyte cell system, as follows.
1. Neutrophils are archetypical phagocytes: As referred before, the
exclusion of neutrophils from the MPS was based on the inter-
pretation that their origin and kinetic and functional behavior
are different from those of monocytes/macrophages, interpre-
tation that, with the advances in knowledge, has been proved
incorrect.
2. Neutrophils, monocytes/macrophages and immature myeloid
DCs have a common origin: The initial view that neutrophils
and macrophages arise from a common late bone marrow
precursor (Metcalf, 1989; Inaba et al., 1993a) has been con-
ﬁrmed by results showing that these phagocytes originate from
hematopoietic stem cells (HSC) which differentiate through
common pathways that also lead to immature myeloid DCs
(Akashi et al., 2000; Iwasaki and Akashi, 2007; Figure 1).
3. Macrophages andneutrophils share important features: Impor-
tant features shared by macrophages and neutrophils with
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respect to their common origin include: (i) avid phagocytic
capabilities (Dale et al., 2008); (ii) presence of common surface
markers like chemokine receptors (Silva, 2010a) and recep-
tors for Igs and complement (Dale et al., 2008), and common
patterns of cytokine and chemokine secretion (Silva, 2010a);
(iii) commonexpressionof pattern recognition receptors (PRR)
(Janeway, 1989); (iv) cooperative participation in the orchestra-
tion of adaptive immune responses (Silva, 2010b); (v) scavenger
capacity [while macrophages are the main scavenger phago-
cyte (Parnaik et al., 2000), neutrophils may function as a
backup system when the scavenging capacity of macrophages
is overwhelmed in situations of hyper-inﬂammation (Rydell-
Tormanen et al., 2006)]; (vi) similarity on the kinetic behav-
ior under inﬂammatory/infectious conditions (Silva, 2010a).
Also to consider are reports on the possible conversion of
neutrophils into macrophages (Araki et al., 2004; Sasmono
et al., 2007). Additionally, two functional criteria that were
taken into consideration to select cells to be grouped in the
MPS, namely pinocytosis and the ability to attach ﬁrmly to
a glass surface (van Furth et al., 1972), are now known to
be exhibited by neutrophils as well (Hoffstein et al., 1981;
Davis et al., 1986).
4. Macrophage/neutrophil functional partnership: The cooper-
ation between the members of a cell system enhances its
functional efﬁciency (Seeley, 2002; Shou et al., 2007). Data
discussed above and elsewhere (Silva, 2010a,b, 2011) indicate
that the MYPS is an assembly of dedicated phagocytic cells that
function in an interacting and cooperative way.
While sharing several functions, macrophages and neutrophils
are specialized cells with functional and function-related mor-
phological distinctive features. These features are complementary
and provide varied levels of antimicrobial capacities and cytotox-
icity, and tissue-speciﬁc localization and lifespan (Silva, 2010a).
These distinctive features explain why macrophages and neu-
trophils are not able to replace each other as central players
of antimicrobial immunity, as indicated by the pathology asso-
ciated with some human and murine phagocyte deﬁciencies
(Dale and Liles, 2002).
The combination of shared and complementary features of
macrophages and neutrophils promotes their cooperative partici-
pation as effectors and modulators in immunity against infection
(Silva,2010a,b). This cooperation is clearly illustrated by the ability
of macrophages, in their process of killing intracellular bacte-
ria, to take up proteins and peptides (e.g., human neutrophil
peptide 1) produced and released by neutrophils. In addition,
macrophages are also able to engulf apoptotic neutrophils and
make use of the antimicrobial molecules present in their granules.
Based on these results (Silva et al., 1989; Sharma et al., 2000; Tan
et al., 2006; Sawant et al., 2010), in 2009 Silva proposed the con-
cept of macrophage/neutrophil partnership in the host response
against infection (Silva, 2010a), a concept extensively reviewed in
Silva (2011).
The framework of the concept of macrophage/neutrophil part-
nership (Silva, 2010a,b, 2011), which is a central facet of the MYPS
system, includes several cooperativemacrophage/neutrophil activ-
ities. (i) At the initiation of the infectious inﬂammation, complex
networks of cytokines and chemokines originate through inter-
action of monocytes/macrophages and neutrophils at the infec-
tious/inﬂammatory foci (Silva, 2010a; Soehnlein and Lindbom,
2010). (ii) Ampliﬁcation of the limited antimicrobial capacity of
macrophages by the acquisition of neutrophil potent microbici-
dal molecules without transit as extracellular damage associated
molecular pattern molecules (DAMPs), thus reducing the harm
due to excessive inﬂammation (Silva et al., 1989; Silva, 2010a).
In situations where macrophages handle diverse intramacrophage
microbes in different ways, antimicrobial components of neu-
trophil granules, acquired by macrophages through uptake of
neutrophils or neutrophil granules, are mobilized to the diverse
types of microbe-containing vacuoles (Silva, 2011). At these loca-
tions the acquired molecules may exert their antimicrobial role
through a direct activity against the intramacrophage pathogens
(Sharma et al., 2000; Tan et al., 2006) or through interaction with
the endogenous macrophage antimicrobial mechanisms (Lincoln
et al., 1995; Marodi et al., 1998). (iii) A non-phagocytic facet of
the interactive cooperation macrophage/neutrophil at the effector
level is the reciprocal activation of monocytes/macrophages and
neutrophils. Monocytes/macrophages can be activated directly by
neutrophil products, including released granule molecules, with
boosting of their phagocytic and antimicrobial capacities (Lima
and Kierszenbaum, 1985; Ichinose et al., 1996; Zughaier et al.,
2005; Soehnlein et al., 2008a,b,c) and neutrophils are activated by
macrophage-secreted cytokines and chemokines and acquire an
inﬂammatory effector phenotype (reviewed in Silva, 2010a). (iv)
Interaction and cooperation results in the resolution of the infec-
tious inﬂammation upon control of the infectious process, as well
(Silva, 2010a; Soehnlein and Lindbom, 2010). A similar concept
was proposed after the initial paper by Silva (Soehnlein and
Lindbom, 2010).
This cooperative partnership represents a factor for increased
efﬁciency of the MYPS. As already noted by Metchnikoff
(1905), the presence of two professional phagocytes is exclu-
sive of the immune system of vertebrates. The cooperation
macrophage/neutrophil within the competences of the MYPS,
allows an immune attack strategy against microbial infections
based on two complementary phagocytes that safely take advan-
tage of powerful neutrophil microbicidal factors that are trans-
ferred to the infected macrophage. This is a safe way of
macrophages to make use of powerful but dangerous microbi-
cidal molecules avoiding the problems of permanently carrying
these cytotoxic factors. This strategy is a target of key virulence
mechanisms of successful pathogens.
CONCLUSION
Based on the principle that phagocyte cell systems must include
all dedicated phagocytic cells, the creation of the MYPS (Silva,
2010a) was proposed, changing the unacceptable prevailing sit-
uation where the only phagocyte cell system in use (MPS)
excludes neutrophils. The members of this system have common
origin and share avid phagocytic abilities. Besides individ-
ual activities of the members of a cellular system, coopera-
tion between them enhances the system’s functional efﬁciency.
Macrophage/neutrophil partnership, important in phagocytic,
immunomodulatory, and inﬂammation pro-resolving activities,
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is particularly relevant in the operation of the MYPS (Silva,
2010a). Thus, neutrophils and macrophages are the main arms
of this system.
In conclusion, the MYPS is a system of dedicated phago-
cytic cells that groups neutrophils, inﬂammatory monocytes,
macrophages, and immature myeloid DCs; these functions in
an interacting and cooperative way in the host defense against
microbial infection.
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